Literature DB >> 27443613

Ebola Virus Shedding and Transmission: Review of Current Evidence.

Pauline Vetter1, William A Fischer2, Manuel Schibler3, Michael Jacobs4, Daniel G Bausch5, Laurent Kaiser3.   

Abstract

BACKGROUND: The magnitude of the 2013-2016 Ebola virus disease outbreak in West Africa was unprecedented, with >28 500 reported cases and >11 000 deaths. Understanding the key elements of Ebola virus transmission is necessary to implement adequate infection prevention and control measures to protect healthcare workers and halt transmission in the community.
METHODS: We performed an extensive PubMed literature review encompassing the period from discovery of Ebola virus, in 1976, until 1 June 2016 to evaluate the evidence on modes of Ebola virus shedding and transmission.
FINDINGS: Ebola virus has been isolated by cell culture from blood, saliva, urine, aqueous humor, semen, and breast milk from infected or convalescent patients. Ebola virus RNA has been noted in the following body fluids days or months after onset of illness: saliva (22 days), conjunctiva/tears (28 days), stool (29 days), vaginal fluid (33 days), sweat (44 days), urine (64 days), amniotic fluid (38 days), aqueous humor (101 days), cerebrospinal fluid (9 months), breast milk (16 months [preliminary data]), and semen (18 months). Nevertheless, the only documented cases of secondary transmission from recovered patients have been through sexual transmission. We did not find strong evidence supporting respiratory or fomite-associated transmission.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus; shedding; transmission

Mesh:

Year:  2016        PMID: 27443613      PMCID: PMC6283352          DOI: 10.1093/infdis/jiw254

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  87 in total

1.  Shedding of Ebola Virus in an Asymptomatic Pregnant Woman.

Authors:  Emma Akerlund; Joseph Prescott; Livia Tampellini
Journal:  N Engl J Med       Date:  2015-06-18       Impact factor: 91.245

2.  Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.

Authors:  Stephan Günther; Heinz Feldmann; Thomas W Geisbert; Lisa E Hensley; Pierre E Rollin; Stuart T Nichol; Ute Ströher; Harvey Artsob; Clarence J Peters; Thomas G Ksiazek; Stephan Becker; Jan ter Meulen; Stephan Olschläger; Jonas Schmidt-Chanasit; Hinrich Sudeck; Gerd D Burchard; Stefan Schmiedel
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

4.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

5.  Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  Y Guimard; M A Bwaka; R Colebunders; P Calain; M Massamba; A De Roo; K D Mupapa; K Kibadi; K J Kuvula; D E Ndaberey; K R Katwiki; B B Mapanda; O B Nkuku; Y Fleerackers; E Van den Enden; M A Kipasa
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  L L Rodriguez; A De Roo; Y Guimard; S G Trappier; A Sanchez; D Bressler; A J Williams; A K Rowe; J Bertolli; A S Khan; T G Ksiazek; C J Peters; S T Nichol
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.

Authors:  Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.

Authors:  Emily P Thi; Chad E Mire; Amy C H Lee; Joan B Geisbert; Joy Z Zhou; Krystle N Agans; Nicholas M Snead; Daniel J Deer; Trisha R Barnard; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

9.  Delivery of an Ebola Virus-Positive Stillborn Infant in a Rural Community Health Center, Sierra Leone, 2015.

Authors:  Hilary Bower; Julian E Grass; Emily Veltus; Aaron Brault; Shelley Campbell; Alison Jane Basile; David Wang; Christopher D Paddock; Bobbie R Erickson; Johanna S Salzer; Jessica Belser; Eunice Chege; Dean Seneca; Gbessay Saffa; Ute Stroeher; Tom Decroo; Grazia M Caleo
Journal:  Am J Trop Med Hyg       Date:  2015-11-10       Impact factor: 2.345

10.  Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports.

Authors:  Séverine Caluwaerts; Tessy Fautsch; Daphne Lagrou; Michel Moreau; Alseny Modet Camara; Stephan Günther; Antonino Di Caro; Benny Borremans; Fara Raymond Koundouno; Joseph Akoi Bore; Christopher H Logue; Martin Richter; Roman Wölfel; Eeva Kuisma; Andreas Kurth; Stephen Thomas; Gillian Burkhardt; Elin Erland; Fanshen Lionetto; Patricia Lledo Weber; Olimpia de la Rosa; Hassan Macpherson; Michel Van Herp
Journal:  Clin Infect Dis       Date:  2015-12-17       Impact factor: 9.079

View more
  60 in total

1.  Is sweat a possible route of transmission of SARS-CoV-2?

Authors:  Ruth E Propper
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-19

2.  Evaluating the Environmental Persistence and Inactivation of MS2 Bacteriophage and the Presumed Ebola Virus Surrogate Phi6 Using Low Concentration Hydrogen Peroxide Vapor.

Authors:  Joseph P Wood; William Richter; Michelle Sunderman; M Worth Calfee; Shannon Serre; Leroy Mickelsen
Journal:  Environ Sci Technol       Date:  2020-03-03       Impact factor: 9.028

3.  Enhancement of Ebola virus infection by seminal amyloid fibrils.

Authors:  Stephen M Bart; Courtney Cohen; John M Dye; James Shorter; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

4.  A Quantitative Framework for Defining the End of an Infectious Disease Outbreak: Application to Ebola Virus Disease.

Authors:  Bimandra A Djaafara; Natsuko Imai; Esther Hamblion; Benido Impouma; Christl A Donnelly; Anne Cori
Journal:  Am J Epidemiol       Date:  2021-04-06       Impact factor: 4.897

Review 5.  Viral Infections in Pregnancy: A Focus on Ebola Virus.

Authors:  Nicole S Olgun
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

6.  Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models.

Authors:  Andrea Marzi; Spencer Chadinah; Elaine Haddock; Friederike Feldmann; Nicolette Arndt; Cynthia Martellaro; Dana P Scott; Patrick W Hanley; Tolbert G Nyenswah; Samba Sow; Moses Massaquoi; Heinz Feldmann
Journal:  Cell Rep       Date:  2018-05-08       Impact factor: 9.423

Review 7.  Therapeutic strategies to target the Ebola virus life cycle.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Nat Rev Microbiol       Date:  2019-07-24       Impact factor: 60.633

8.  Household Transmission of Ebola Virus: Risks and Preventive Factors, Freetown, Sierra Leone, 2015.

Authors:  Mary R Reichler; James Bangura; Dana Bruden; Charles Keimbe; Nadia Duffy; Harold Thomas; Barbara Knust; Ishmail Farmar; Erin Nichols; Amara Jambai; Oliver Morgan; Thomas Hennessy
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

Review 9.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

Review 10.  Ebola virus disease: an update on post-exposure prophylaxis.

Authors:  William A Fischer; Pauline Vetter; Daniel G Bausch; Timothy Burgess; Richard T Davey; Robert Fowler; Frederick G Hayden; Peter B Jahrling; Andre C Kalil; Douglas L Mayers; Aneesh K Mehta; Timothy M Uyeki; Michael Jacobs
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.